A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study

Nitta, E. ; Izutsu, K. ; Sato, T. ; Ota, Y. ; Takeuchi, K. ; Kamijo, A. ; Takahashi, K. ; Oshima, K. ; Kanda, Y. ; Chiba, S. ; Motokura, T. ; Kurokawa, M.

Annals of oncology, 2007-02, Vol.18 (2), p.364-369 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível